David Huntsman

Canada Research Chair in Molecular and Genomic Pathology

Tier 1 - 2017-11-01
Renewed: 2022-10-01
The University of British Columbia
Canadian Institutes of Health Research

604-877-6000, ext./poste 2148

Research involves

Using pathology and genomics tools to better understand how ovarian cancers development and developing improved prevention and treatment strategies.

Research relevance

This research will increase our understanding of what drives cancer and how we can better diagnose, treat and prevent this disease.

Research summary

Ovarian cancer is considered the most serious cancer for women. It has been called a “silent killer” because some women notice symptoms only after the disease has reached an advanced stage. As Canada Research Chair in Molecular and Genomic Pathology, Dr. David Huntsman is studying ovarian cancer in hopes of coming up with better ways to prevent and treat it. 

He and his research team are exploring a hypothesis that the highly specific cancer types found in the ovary arise from interactions between cells of origin, mutations and their microenvironment—and that only by understanding these interactions will it be possible to come up with the best prevention, diagnosis and treatment strategies. Huntsman and his team are working on four related research projects that are poised to contribute to the understanding of ovarian cancers.